Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptor-deficient mutants

Neoplasia

Volumn 8, Issue 12, 2006, Pages 984-994

  Aravindakshan, Jayaprakash ^a   Chen, Xinlei ^a   Sairam, M Ram ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Aging; FSH receptor; Ovary; Tight junctions; Tumors

Indexed keywords

CLAUDIN 1; CLAUDIN 11; CLAUDIN 3; CLAUDIN 4; FOLLITROPIN RECEPTOR; MESSENGER RNA; STEROID HORMONE; CLDN11 PROTEIN, MOUSE; MEMBRANE PROTEIN; NERVE PROTEIN; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL JUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HORMONAL REGULATION; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ADENOMA; AGE; ANIMAL; BIOSYNTHESIS; CELL LINE; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUSE MUTANT; OVARY; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY;

ADENOMA; AGE FACTORS; ANIMALS; CELL LINE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; NERVE TISSUE PROTEINS; OVARIAN NEOPLASMS; OVARY; RECEPTORS, FSH; UP-REGULATION;

EID: 33845579122     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.06529     Document Type: Article

References (34)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, and Thun MJ (2005). Cancer statistics, 2005. Ca Cancer J Clin 55, 10-30.
2. Lukanova A and Kaaks R (2005). Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomark Prev 14, 98-107.
3. Zanagnolo V, Sartori E, Trussardi E, Pasinetti B, and Maggino T (2005). Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors. Eur J Obstet Gynecol Reprod Biol 123, 235-243.
4. Bell DA (2005). Origins and molecular pathology of ovarian cancer. Mod Pathol 18, S19-S32.
5. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R, and Wu AH (2002). Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155, 217-224.
6. Konishi I (2006). Gonadotropins and ovarian carcinogenesis: a new era of basic research and its clinical implications. Int J Gynecol Cancer 16, 16-22.
7. Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, and Hamilton TC (2003). Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63, 1389-1397.
8. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, and Sassone-Corsi P (1998). Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 95, 13612-13617.
9. Danilovich N, Roy I, and Sairam MR (2001). Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice. Endocrinology 142, 3673-3684.
10. Chen XL, Aravindakshan J, Yang Y, and Sairam MR (2005). Alterations in ovarian surface epithelium and age dependent propensity for ovarian tumors in FSH receptor knockout (FORKO) female mice. Fertil Steril 84, S61.
11. Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, Davies MJ, Heinzelmann M, Kalish LH, Bali A, Kench JG, et al. (2004). Overexpression of the cell adhesion molecules DDR1, claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res 10, 4427-4436.
12. Hibbs K, Skubitz KM, Pambuccian SE, Casey RC, Burleson KM, Oegema TR, Thiele JJ, Grindle SM, Bliss RL, and Skubitz APN (2004). Differential gene expression in ovarian carcinoma - identification of potential biomarkers. Am J Pathol 165, 397-414.
13. Rangel LBA, Agarwal R, D'Souza T, Pizer ES, Alo PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, and Morin PJ (2003). Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9, 2567-2575.
14. Zhu YH, Brannstrom M, Janson PO, and Sundfeldt K (2006). Differences in expression patterns of the tight junction proteins, claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours. Int J Cancer 118, 1884-1891.
15. Roby KF, Taylor CC, Sweetwood JP, Cheng Y, Pace JL, Tawfik O, Persons DL, Smith PG, and Terranova PF (2000). Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21, 585-591.
16. Danilovich N, Babu PS, Xing WR, Gerdes M, Krishnamurthy H, and Sairam MR (2000). Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141, 4295-4308.
17. Chen XL, Aravindakshan J, Yang YZ, Tiwari-Pandey R, and Sairam MR (2006). Aberrant expression of PDGF ligands and receptors in the tumor prone ovary of follitropin receptor knockout (FORKO) mouse. Carcinogenesis 27, 903-915.
18. Morin PJ (2005). Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65, 9603-9606.
19. Bronstein JM, Tiwari-Woodruff S, Buznikov AG, and Stevens DB (2000). Involvement of OSP/Claudin-11 in oligodendrocyte membrane interactions: role in biology and disease. J Neurosci Res 59, 706-711.
20. Risch HA (1998). Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90, 1774-1786.
21. Ho SM (2003). Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol 1, 73.
22. Abel MH, Huhtaniemi I, Pakarinen P, Kumar TR, and Charlton HM (2003). Age-related uterine and ovarian hypertrophy in FSH receptor knockout and FSH beta subunit knockout mice. Reproduction 125, 165-173.
23. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, and Nilson JH (1995). Targeted overexpression of luteinizing-hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian-tumors. Proc Natl Acad Sci USA 92, 1322-1326.
24. Tsukita S, Furuse M, and Itoh M (2001). Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2, 285-293.
25. Mitic LL and Anderson JM (1998). Molecular architecture of tight junctions. Annu Rev Physiol 60, 121-142.
26. Hewitt KJ, Agarwal R, and Morin PJ (2006). The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6, 186-189.
27. Agarwal R, D'Souza T, and Morin P (2005). Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65, 7378-7385.
28. Zhu YH, Maric J, Nilsson M, Brannstrom M, Janson RO, and Sundfeldt K (2004). Formation and barrier function of tight junctions in human ovarian surface epithelium. Biol Reprod 71, 53-59.
29. Kramer F, White K, Kubbies M, Swisshelm K, and Weber BHF (2000). Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 107, 249-256.
30. Tokes AM, Kulka J, Paku S, Szik A, Paska C, Novak PK, Szilak L, Kiss A, Bogi K, and Schaff Z (2005). Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7, R296-R305.
31. Resnick MB, Konkin T, Routhier J, Sabo E, and Pricolo VE (2005). Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18, 511-518.
32. Van Itallie CM and Anderson JM (2004). The molecular physiology of tight junction pores. Physiology 19, 331-338.
33. Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A, and Roskelley CD (1999). E-cadherin induces mesenchymal-to- epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 96, 6249-6254.
34. Pon YL, Auersperg N, and Wong AST (2005). Gonadotropins regulate N-cadherin-mediated human ovarian surface epithelial cell survival at both post-translational and transcriptional levels through a cyclic AMP/protein kinase a pathway. J Biol Chem 280, 15438-15448.